The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.
It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
Working Group on Cardiovascular Pharmacotherapy members can receive the journal for 30 EUR.
ESC Professional and Professional Plus Members can receive the journal for 40 EUR.
Become a member
Receive Table of contents in your mailbox.
Track the topics, authors and articles important to you and receive articles in your mailbox.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved